Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,115 | 1 | 93.0% |
| Food and Beverage | $234.53 | 4 | 7.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alnylam Pharmaceuticals Inc. | $3,115 | 1 | $0 (2020) |
| Vanda Pharmaceuticals Inc. | $156.20 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $57.53 | 1 | $0 (2017) |
| Relypsa, Inc. | $20.80 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $52.14 | 1 | Vanda Pharmaceuticals Inc. ($52.14) |
| 2023 | $104.06 | 1 | Vanda Pharmaceuticals Inc. ($104.06) |
| 2020 | $3,115 | 1 | Alnylam Pharmaceuticals Inc. ($3,115) |
| 2017 | $78.33 | 2 | Alexion Pharmaceuticals, Inc. ($57.53) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/20/2024 | Vanda Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $52.14 | General |
| 01/13/2023 | Vanda Pharmaceuticals Inc. | — | Food and Beverage | In-kind items and services | $104.06 | General |
| 09/24/2020 | Alnylam Pharmaceuticals Inc. | OXLUMO (Drug) | Consulting Fee | Cash or cash equivalent | $3,115.00 | General |
| Category: Genetic Disease | ||||||
| 04/28/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: Hyperkalemia | ||||||
| 03/03/2017 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Drug) | Food and Beverage | In-kind items and services | $57.53 | General |
| Category: Immunology | ||||||
About Onur Cil, MD, PHD
Onur Cil, MD, PHD is a Pediatric Nephrology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2016. The National Provider Identifier (NPI) number assigned to this provider is 1851741540.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Onur Cil, MD, PHD has received a total of $3,350 in payments from pharmaceutical and medical device companies, with $52.14 received in 2024. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($3,115).
Practice Information
- Specialty Pediatric Nephrology
- Location San Francisco, CA
- Active Since 06/14/2016
- Last Updated 06/14/2016
- Taxonomy Code 2080P0210X
- Entity Type Individual
- NPI Number 1851741540
Products in Payments
- OXLUMO (Drug) $3,115
- SOLIRIS (Drug) $57.53
- Veltassa (Drug) $20.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.